Ponatinib in chronic myeloid leukaemia: ready for first-line?

被引：0
|
作者：
Breccia, Massimo [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00161 Rome, Italy
来源：
LANCET HAEMATOLOGY | 2015年 / 2卷 / 09期
关键词：
FOLLOW-UP; IMATINIB;
D O I：
10.1016/S2352-3026(15)00130-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E352 / E353
页数：2
相关论文
共 50 条
  • [41] Clinical significance of serum prohibitin in chronic myeloid leukemia patients on first-line tyrosine kinase inhibitors
    Yassin, Heba A.
    Azaazi, Mohamed O.
    Hegab, Hany M.
    Nabih, Nermine A.
    Rakha, Nahed M.
    Naguib, Mary G.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (01) : 55 - 57
  • [42] Dose optimisation of ponatinib in chronic phase chronic myeloid leukemia
    Huguet, Francoise
    Rea, Delphine
    Cayssials, Emilie
    Etienne, Gabriel
    Nicolini, Franck-Emmanuel
    EXPERT REVIEW OF HEMATOLOGY, 2023,
  • [43] First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia
    Rea, D.
    Etienne, G.
    Nicolini, F.
    Cony-Makhoul, P.
    Johnson-Ansah, H.
    Legros, L.
    Huguet, F.
    Tulliez, M.
    Gardembas, M.
    Bouabdallah, K.
    Rousselot, P.
    Cayuela, J-M
    Guilhot, F.
    Mahon, F-X
    LEUKEMIA, 2012, 26 (10) : 2254 - 2259
  • [44] First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies
    Gabriele Gugliotta
    Fausto Castagnetti
    Michela Apolinari
    Sara Pirondi
    Michele Cavo
    Michele Baccarani
    Gianantonio Rosti
    Drugs, 2014, 74 : 627 - 643
  • [45] Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib
    Marin, David
    Hedgley, Corinne
    Clark, Richard E.
    Apperley, Jane
    Foroni, Letizia
    Milojkovic, Dragana
    Pocock, Christopher
    Goldman, John M.
    O'Brien, Stephen
    BLOOD, 2012, 120 (02) : 291 - 294
  • [46] Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia
    Baran, Yusuf
    Saydam, Guray
    JOURNAL OF BLOOD MEDICINE, 2012, 3 : 139 - 150
  • [47] First-Line Treatment of Newly Diagnosed Elderly Patients with Chronic Myeloid Leukemia: Current and Emerging Strategies
    Gugliotta, Gabriele
    Castagnetti, Fausto
    Apolinari, Michela
    Pirondi, Sara
    Cavo, Michele
    Baccarani, Michele
    Rosti, Gianantonio
    DRUGS, 2014, 74 (06) : 627 - 643
  • [48] Safety profiles of second-line tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
    Tinsley, Sara M.
    JOURNAL OF CLINICAL NURSING, 2010, 19 (9-10) : 1207 - 1218
  • [49] Current opinions and controversies in chronic myeloid leukaemia
    Kishore, Bhuvan
    Marin, David
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 659 - 664
  • [50] Current approach to the treatment of chronic myeloid leukaemia
    Pasic, Ivan
    Lipton, Jeffrey H.
    LEUKEMIA RESEARCH, 2017, 55 : 65 - 78
12345